Page 12 - DHC-new 25 sept[53209]

What Our engines are ready to catapult Deccan

Healthcare into the round of growth.
Our progressing business model is at the
inspires us? achieved in the last twenty one years will
apex of a phase where whatever we have
enhance value for all our stakeholders.

Our Passion is to bring Deccan Healthcare
HAPPIness*HeAlTH*WeAlTH
ERADICATE MICRONUTRIENT DEFICIENCY TO END The Inception

DHC is a fully integrated FMCH product company
managing the entire supply chain from farm to
consumer. By leveraging and optimizing all aspects
of our extensive value chain, it has been possible for
us to respond with speed and flexibility to emerging
opportunities.

The company has demonstrated an ability to evolve,
grow and shape its responses to change in its
journey of growth, working towards its mission to Founded as a pharmaceutical company in mid-year 1996 government and affected the pricing of such drugs
eradicate Micronutrient Deficiency (MND) and bring has been working towards value-accruing improvements adversely. As a result this made medicines expensive,
Our consumers live by our shared Happiness*Health*Wealth. and innovations in a differentiated way. the company’s portfolio of products lost its low-cost
advantage. Apart from this, with the announcement

values and commitment; And we are The breadth and depth of the company’s powerful We continued to focus on the development of products, of special benefit states induced pharma units to
driven by a passion to improve health, portfolio across innovations, brands, FMCHP categories, delivering therapies that serve patient needs around the move into these special states. We then relocated our
manufacturing to Himachal Pradesh to maintain our
world. Our aim harmonizes with global relevance, with
geographies, supported by strong manufacturing
the company moves on to reaching infrastructure and operational excellence is unmatched. the objective of affordability and accessibility, which we competitive landscape. The company adapting to
the next level of excellence. The company’s innovation emphasis is spread across believe represents the foundation of our enterprise. current market dynamics, post move, had an impact on
manufacturing due to lack of the initial infrastructure
five focus channels that the company feels address By creating necessary building blocks, extending from and skilled manpower. After adjusting to the situation,
Wealth. Of. Wellness. We see and experience this each unmet consumer needs and will drive sustainable innovation at one end to patient-centricity at the other, profitability, growth and performance got impacted due
day at work, where our Deccan Healthcare team across growth. These five income /revenue channels of the we have been able to look at the pharma value chain to uncertainty based on multiple issues in regulatory,
geographies are innovating, engaging, creating and company are working towards relentlessly increasing and bring exciting possibilities. pricing and competitive dynamics.
delivering nutritional solutions that consumers need geographic footprint and deliver consumer relevant
around the world. FMCH products to acquire and engage 20 lac In view of this, ethical commitment and compliance Moving forward, the pressure to reduce costs, increase
consumers. We find that this happens in a seamless are intrinsic to business sustainability. Doing things, the efficiency, and prove value remained intense. We adapted
Deccan Healthcare (DHC) today is known as an FMCH way when our consumers live by our shared values and right way has made it possible to achieve desired results, to the change, reset goals and rebuild on our values and
category company with Healthy Lifestyle Products commitment; are driven by a passion to improve health, eliminated re-work, removed mismatches between commitment - “Quality medicines at low cost”. In the first
providing effective nutritional solutions for many the company moves on to reaching the next level of expectations and reality and made our outcomes more decade of the millennium, economic liberalization and
preventable disorders and diseases. We prudently excellence of Rupees 1000 Crores annual income with predictable. high GDP growth in India revolutionized the healthcare
selected to be present in relatively under-crowded an EBIDTA of 35% plus. sector. Growing population and income gave rise to
preventive healthcare and self-care spaces with The life sciences sector’s growth correlates highly more diseases and more so these diseases are termed
moderate entry barriers, promising attractive long- with countries’ general economic strength and health as lifestyle diseases. Spending growth in the care and
term returns. care spending levels, and both vary widely around the management of these diseases became the sectors
globe. In its inception years, we were producing and focus, and resulted in new pharma products, more and
making quality medicines and offering these at a more better equipped hospitals, better disease management
The DHC products are bridging the gap between the
food we take and the food we must take, and the way affordable price to consumers as quality generics. techniques and surgical procedures. The evolution
we live and the way we should live. DHC products help changed the disease pattern. Diseases like Malaria, TB,
consumers “Stay WOW” lifelong. Demand for our generic drugs continued to rise as seasonal diarrhea and water-borne diseases were getting
payers pursued avenues to reduce costs. Our strategic eradicated and new diseases were becoming a cause
direct company to consumer supply chain cut down of concern. It was evident that R&D pharmaceuticals is
Our products offer the consumers a new revived
option to protect themselves from over 200 diseases, the cost of distribution and made DHC medicines more projected to follow an upward trend due to increasing
disorders, disabilities and symptoms with simple FMCH affordable for consumers. In the early years DHC was demand to address these new emerging diseases.
– products. These products help consumers achieve recognized for its “Quality medicines at low cost”.
their health goals that aim to be disease free, vital, With the boom of inventions in healthcare, pharmaceuticals,
energetic, and productive and enjoy good quality of In a short span after its launch, the company had and procedures, the cost of healthcare amplified concerning
life lifelong. achieved an enviable status and constant growth. With patients and governments across the globe as budgetary
the onset of new government regulations in the year 2005 allocations started moving upwards. It was progressively
for the Indian pharmaceutical industry, companies began evident that cost control will be the government focus
We intend to enhance sustainable long-term value
through a robust innovation-driven and manufacturing- to face challenges impacting growth. and be it with introduction of price control on medicines.
led strategy. We will continue to delve deeper and Industry exclaimed aggressively yet the government
explore the entire spectrum of innovation from With excise being levied on the maximum retail price could not be lobbied.
dietary and sports supplements and new nutraceutical of medicines, the medicines gave more revenue to the
technologies to bridge unmet healthcare needs.